zepbound tirzepatide - Search News

News

People lost more weight on Zepbound

CBS News · 15h

Zepbound tops Wegovy for weight loss in first head-to-head study comparing the drugs

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

MarketWatch on MSN · 16h

Here’s how much extra weight is lost with Zepbound over Wegovy

A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their waists compared with Novo Nordisk’s rival Wegovy. At 72 weeks, participants using Zepbound saw an average weight-loss reduction of 20.

MedPage Today on MSN · 10h

Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial.

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Applied Clinical Trials Online15h

Tirzepatide Demonstrates Superior Weight Loss to Semaglutide in 72-Week Phase IIIb SURMOUNT-5 Trial

In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results